Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR)

Cancer Letters

Volumn 176, Issue 1, 2002, Pages 93-99

  Nagakawa, Osamu ^a   Murata, Jun ^b   Junicho, Akira ^a   Matsuda, Tadashi ^a   Fujiuchi, Yasuyoshi ^a   Fuse, Hideki ^a   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Faculty of Bioresource Sciences   (Japan)

Author keywords

Androgen receptor; Migration; Prostate carcinoma; Vasoactive intestinal peptide

Indexed keywords

ANDROGEN RECEPTOR; COMPLEMENTARY DNA; FIBRONECTIN; MESSENGER RNA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

BLOTTING, WESTERN; CELL DIVISION; CELL MOVEMENT; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRONECTINS; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0037039717     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00737-6     Document Type: Article

References (39)

1. Potent peripheral and splanchnic vasodilator peptide from normal gut
2. Polypeptide with broad biological activity: Isolation from small intestine
3. Vasoactive intestinal polypeptide in brain: Localization in and release from isolated nerve terminals
4. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions
5. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
6. 2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide
7. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor
8. Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor
9. Cloning and expression of the human vasoactive intestinal peptide receptor
10. Effect of VIP infusion on water and ion transport in the human jejunum
11. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide
12. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide
13. VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion
14. Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells
15. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line
16. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist
17. Vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth
18. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells
19. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts
20. The human prostate gland: A histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine [beta]-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia
21. Structure, expression and chromosomal localization of the type1 human vasoactive intestinal peptide receptor gene
22. Cyclic AMP response to vasoactive intestinal peptide and [beta]-adrenergic or cholinergic agonist in isolated epithelial cells of rat ventral prostate
23. Vasoactive intestinal peptide stimulates prostate-specific antigen secretion by LNCaP cells
24. In vitro identification of vasoactive intestinal peptide receptors in human tumors: Implications for tumor imaging
25. Neuroendocrine peptides stimulates adenyl cyclase in normal and malignant prostate cells
26. Differential effect of peptide hormones bombesin, vasoactive intestinal polypeptide, and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells
27. Effect of prostatic neuropeptides on migration of prostate cancer cell lines
28. Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells
29. Type 1 vasoactive intestinal peptide receptor expression in PC3/AR cells in evidence of prostate epithelial differentiation
30. CREB-binding protein in androgen receptor-mediated signaling
31. SOCS-1 can suppress CD3ζ- and Syk-mediated NF-AT activation in a non-lymphoid cell line
32. 4-[3,5-Bis(trimethylsilyl)benzamindo] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor bearing animals
33. Inhibition of tumor cell invasion by Ubenimex (Bestatin) in vitro
34. A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors
35. Inhibitory effect of vasoactive intestinal peptide (VIP) on experimental liver metastasis by murine colon 26-L5 carcinoma cells
36. Alpha-melanocyte stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells
37. Vasoactive intestinal peptide: Biologic role in health and disease
38. Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP/PACAP, ATP and carbachol. Role in prostatic proliferation
39. Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanism: Evidence from in vitro studies on human prostatic and pancreatic cancers